diabetes complications/protease

Lyen an sove nan clipboard la

AtikEsè klinikPatant

Chwazi kalite sòt

Paj 1 soti nan 57 rezilta yo

An Overview on ATP Dependent and Independent Proteases Including an Anterograde to Retrograde Control on Mitochondrial Function; Focus on Diabetes and Diabetic Complications.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Mitochondria are the central power stations of the cell involved with a myriad of cell signalling pathways that contributes for whole health status of the cell. It is well known fact not only mitochondrial genome encodes for mitochondrial proteins but also there are several mitochondrial specific

Protease inhibitor-induced diabetic complications : incidence, management and prevention.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Protease inhibitors (PIs) have become a crucial element in the treatment of patients infected with HIV. However, the widespread use of PI therapy has also been associated with a number of metabolic adverse effects, including fat redistribution and hyperglycaemia. The objective of this review is a

Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Endothelial dysfunction is a central pathomechanism in diabetes-associated complications. We hypothesized a pathogenic role in this dysfunction of cathepsin S (Cat-S), a cysteine protease that degrades elastic fibers and activates the protease-activated receptor-2 (PAR2) on endothelial cells. We

Protease profiling of different biofluids in type 1 diabetes mellitus.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE We aimed to disclose the proteolytic events underlying type 1 diabetes and related complication through protease profiling in the bodily fluids serum, urine and saliva. METHODS Zymography followed by LC-MS/MS was performed for protease identification and quantitative comparison of

Protease activated receptor 2 in diabetic nephropathy: a double edged sword.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Diabetic nephropathy is a major microvascular complication of diabetes mellitus, and the leading cause of end stage renal disease worldwide. The pathogenesis of diabetic nephropathy is complex, making the development of novel treatments that stop or reverse the progression of microalbuminuria into

Hyperglycemia potentiates carbonyl stress-induced apoptosis in naïve PC-12 cells: relationship to cellular redox and activator protease factor-1 expression.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The mechanism(s) of central nervous system complication associated with neurodegenerative disorders such as diabetes is unknown. Previous studies demonstrated that carbonyl stress induced by methylglyoxal (MG) mediates differential apoptosis of rat pheochromocytoma (PC12) cells in the naïve or

In vitro and in vivo prevention of HIV protease inhibitor-induced insulin resistance by a novel small molecule insulin receptor activator.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Protease inhibitor (PI) therapy for the treatment of patients infected with human immunodeficiency virus is frequently associated with insulin resistance and diabetic complications. These adverse effects of PI treatment result to a large extent from their inhibition of insulin-stimulated glucose

Proteases and protease inhibitors of urinary extracellular vesicles in diabetic nephropathy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Diabetic nephropathy (DN) is one of the major complications of diabetes mellitus (DM), leads to chronic kidney disease (CKD), and, ultimately, is the main cause for end-stage kidney disease (ESKD). Beyond urinary albumin, no reliable biomarkers are available for accurate early diagnostics. Urinary

Proteomic analysis of protease resistant proteins in the diabetic rat kidney.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Glycation induced protein aggregation has been implicated in the development of diabetic complications and neurodegenerative diseases. These aggregates are known to be resistant to proteolytic digestion. Here we report the identification of protease resistant proteins from the streptozotocin induced

Proteases in Plasma and Kidney of db/db Mice as Markers of Diabetes-Induced Nephropathy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Db/db mice are overweight, dyslipidemic and develop diabetic complications, relevant for similar complications in human type 2 diabetes. We have used db/db and db/+ control mice to investigate alterations in proteinase expression and activity in circulation and kidneys by SDS-PAGE zymography,

Urinary protein profiles in a rat model for diabetic complications.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Diabetes mellitus is estimated to affect approximately 24 million people in the United States and more than 150 million people worldwide. There are numerous end organ complications of diabetes, the onset of which can be delayed by early diagnosis and treatment. Although assays for diabetes are well

Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Diabetes mellitus is characterized by a lack of insulin causing elevated blood glucose, often with associated insulin resistance. Over time, especially in genetically susceptible individuals, such chronic hyperglycemia can cause tissue injury. One pathological response to tissue injury is the

Advanced glycation end-products and cathepsin cysteine protease in type 2 diabetic patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND In type 2 diabetes, chronic hyperglycemia induces multi-faceted disturbances and contributes to late diabetic complications. Nonenzymatic glycation, leading to formation of advanced glycation end-products (AGEs), is one of the most important consequences of hyperglycemia. Alterations in

Advanced glycation end products impair protein turnover in LLC-PK1: amelioration by trypsin.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Advanced glycation end products (AGEs) are assumed to play a key role in the pathogenesis of diabetic nephropathy (DN) and other diabetic complications. While AGEs have been shown to exert marked effects on mesangial and endothelial cells as well as on monocytes/macrophages, little is

Carnosine and its possible roles in nutrition and health.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The dipeptide carnosine has been observed to exert antiaging activity at cellular and whole animal levels. This review discusses the possible mechanisms by which carnosine may exert antiaging action and considers whether the dipeptide could be beneficial to humans. Carnosine's possible biological

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye